{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:32:13Z","timestamp":1791196333387,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2012,10,15]],"date-time":"2012-10-15T00:00:00Z","timestamp":1350259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>To compare mortality among patients with selected autoimmune diseases treated with anti\u2010tumor necrosis factor alpha (TNF\u2010\u03b1) agents with similar patients treated with non\u2010biologic therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cohort study set within several large health care programs, 1998\u20132007. Autoimmune disease patients were identified using diagnoses from computerized healthcare data. Use of anti\u2010TNF\u2010\u03b1 agents and comparison of non\u2010biologic therapies were identified from pharmacy data, and mortality was identified from vital records and other sources. We compared new users of anti\u2010TNF\u2010\u03b1 agents to new users of non\u2010biologic therapies using propensity scores and Cox proportional hazards analysis to adjust for baseline differences. We also made head\u2010to\u2010head comparisons among anti\u2010TNF\u2010\u03b1 agents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 46\u2009424 persons included in the analysis, 2924 (6.3%) had died by the end of follow\u2010up, including 1754 (6.1%) of the 28\u2009941 with a dispensing of anti\u2010TNF\u2010\u03b1 agent and 1170 (6.7%) of the 17\u2009483 who used non\u2010biologic treatment alone. Compared to use of non\u2010biologic therapies, use of anti\u2010TNF\u2010\u03b1 therapy was not associated with an increased mortality in patients with rheumatoid arthritis (adjusted hazard ratio [aHR] 0.93 with 95% confidence intervals (CI) 0.85\u20131.03); psoriasis, psoriatic arthritis, or ankylosing spondylitis (combined aHR 0.81 with CI 0.61\u20131.06; or inflammatory bowel disease (aHR 1.12 with CI 0.85\u20131.46). Mortality rates did not differ to an important degree between patients treated with etanercept, adalimumab, or infliximab.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Anti\u2010TNF\u2010\u03b1 therapy was not associated with increased mortality among patients with autoimmune diseases. Copyright \u00a9 2012 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.3354","type":"journal-article","created":{"date-parts":[[2012,10,15]],"date-time":"2012-10-15T06:36:53Z","timestamp":1350283013000},"page":"1311-1320","source":"Crossref","is-referenced-by-count":27,"title":["Association between anti\u2010TNF\u2010\u03b1 therapy and all\u2010cause mortality"],"prefix":"10.1002","volume":"21","author":[{"given":"Lisa J.","family":"Herrinton","sequence":"first","affiliation":[{"name":"Division of Research Kaiser Permanente  Oakland CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Research Kaiser Permanente  Oakland CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Chen","sequence":"additional","affiliation":[{"name":"UAB Center for Education and Research and Therapeutics of Musculoskeletal Disorders University of Alabama at Birmingham  Birmingham AL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie R.","family":"Harrold","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Department of Medicine, University of Massachusetts Medical School Meyers Primary Care Institute and Fallon Clinic  Worcester MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha A.","family":"Raebel","sequence":"additional","affiliation":[{"name":"Institute for Health Research Kaiser Permanente Colorado  Denver CO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[{"name":"UAB Center for Education and Research and Therapeutics of Musculoskeletal Disorders University of Alabama at Birmingham  Birmingham AL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie R.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Departments of Preventive Medicine and Medicine, Vanderbilt University School of Medicine and the Mid\u2010South Geriatric Research Education and Clinical Center Veterans Administration Tennessee Valley Health Care System  Nashville TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Division of Pharmacoepidemiology Brigham and Women's Hospital  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G.","family":"Saag","sequence":"additional","affiliation":[{"name":"UAB Center for Education and Research and Therapeutics of Musculoskeletal Disorders University of Alabama at Birmingham  Birmingham AL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Department of Biostatistics and Epidemiology University of Pennsylvania  USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,10,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1692"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2383"},{"key":"e_1_2_7_5_1","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson LT","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.067660"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.129916"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.102103"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27660"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.163642"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.191015"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2196"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181d59541"},{"key":"e_1_2_7_14_1","unstructured":"Medicaid Analytic eXtract (MAX) General Information.http:\/\/www.cms.gov\/ MedicaidDataSourcesGenInfo\/07_MAXGeneralInformation.asp. Accessed February 15 2011."},{"key":"e_1_2_7_15_1","unstructured":"Tennessee Government.TennCare.http:\/\/www.tn.gov\/tenncare\/news.html. Accessed February 15 2011."},{"key":"e_1_2_7_16_1","unstructured":"State of New Jersey.Department of Health and Human Services. Pharmaceutical Assistance to the Aged and Disabled (PAAD).http:\/\/www.state.nj.us\/health\/seniorbenefits\/ paad.shtml. Accessed February 15 2011."},{"key":"e_1_2_7_17_1","unstructured":"Pennsylvania Department of Aging.Prescription Assistance (PACE).http:\/\/www.portal.state.pa.us\/portal\/server.pt\/community\/prescription_assistance\/17942. Accessed February 15 2011."},{"key":"e_1_2_7_18_1","unstructured":"Kaiser Permanente Division of Research.Member Health Survey.http:\/\/www.dor.kaiser.org\/external\/DORExternal\/mhs\/index.aspx. Accessed February 15 2011."},{"key":"e_1_2_7_19_1","unstructured":"Health and Human Services Dept. Centers for Disease Control and Prevention; and Centers for Medicare and Medicaid Services.International Classification of Diseases Ninth Revision Clinical Modification (ICD\u20109\u2010CM).2010."},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi106"},{"key":"e_1_2_7_21_1","first-page":"437","article-title":"Fiducial limits for the Poisson distribution","volume":"28","author":"Garwood F","year":"1936","journal-title":"Biometrika"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1989.10478874"},{"key":"e_1_2_7_23_1","unstructured":"Centers for Disease Control and Prevention.National Vital Statistics System. Worktable\u200923R. Death Rates by 10\u2010year age groups: United States and each State 2002.http:\/\/www.cdc.gov\/nchs\/data\/dvs\/mortfinal2002_work23r.pdf. Accessed July 14 2011."},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22979"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201101-0089OC"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3354","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.3354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T04:26:07Z","timestamp":1700540767000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,15]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1002\/pds.3354"],"URL":"https:\/\/doi.org\/10.1002\/pds.3354","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,15]]}}}